Hayat J O, Loew C J, Asrress K N, McIntyre A S, Gorard D A
Department of Gstroenterology, Wycombe Hospital, Queen Alexandra Road, High Wycombe, Bucks HP11 2TT, UK.
QJM. 2005 Jan;98(1):35-40. doi: 10.1093/qjmed/hci004.
Obstructive jaundice is believed to be characterized by abnormalities of alkaline phosphatase (ALP), rather than aspartate transaminase (AST).
To compare liver function tests (LFTs) in obstructive jaundice due to malignant strictures with those of jaundice due to gallstones.
LFTs were measured immediately before endoscopic retrograde cholangio-pancreatography (ERCP) in 207 jaundiced patients. Group 1 (n = 69) had malignant strictures, group 2 (n = 97) had common bile duct stone(s), and group 3 (n = 41) appeared to have recently passed a stone. LFTs in groups 2 and 3 were also analysed at maximal liver enzyme derangement, maximum hyperbilirubinaemia and during acute pain episodes.
Group 1 had higher median bilirubin, AST and ALP levels than groups 2 or 3 (p < 0.001). In group 1, median rise in ALP exceeded that in AST (4.3 x normal upper limit (NUL) vs. 2.6 x NUL, p < 0.01), but in groups 2 and 3, AST and ALP were similarly elevated (both approximately 2 x NUL). At the time of maximum enzyme derangement in groups 2 and 3, median AST elevation (4.4 x NUL, 185 IU/l) exceeded that for ALP (2.4 x NUL, 276 U/l), (p < 0.001), and this was also true at peak hyperbilirubinaemia in these groups (AST 3.6 x NUL, ALP 2.4 x NUL, p < 0.01. Similarly, severe pain episodes in groups 2 and 3 were accompanied by greater elevations in bilirubin and AST, but not ALP, compared with levels at ERCP.
The conventional wisdom that ALP rises more than AST in obstructive jaundice holds true where the jaundice is due to strictures, but in obstructive stone disease, the rise in AST may equal that in ALP, or even exceed it during maximum jaundice and during painful episodes. Clinicians should consider the possibility of extrahepatic biliary obstruction, even when AST is the predominantly elevated enzyme.
梗阻性黄疸被认为以碱性磷酸酶(ALP)异常为特征,而非天冬氨酸转氨酶(AST)。
比较恶性狭窄所致梗阻性黄疸与胆结石所致黄疸患者的肝功能检查(LFTs)结果。
对207例黄疸患者在内镜逆行胰胆管造影(ERCP)前即刻进行LFTs检测。第1组(n = 69)为恶性狭窄患者,第2组(n = 97)为胆总管结石患者,第3组(n = 41)似乎近期有结石排出。还对第2组和第3组在肝酶最大紊乱、最大高胆红素血症时以及急性疼痛发作期间的LFTs进行了分析。
第1组的胆红素、AST和ALP水平中位数高于第2组或第3组(p < 0.001)。在第1组中,ALP的中位数升高超过AST(4.3倍正常上限(NUL)对2.6倍NUL,p < 0.01),但在第2组和第3组中,AST和ALP升高程度相似(均约为2倍NUL)。在第2组和第3组肝酶最大紊乱时,AST升高的中位数(4.4倍NUL,185 IU/l)超过ALP(2.4倍NUL,276 U/l)(p < 0.001),在这些组的高胆红素血症峰值时也是如此(AST 3.6倍NUL,ALP 2.4倍NUL,p < 0.01)。同样,与ERCP时的水平相比,第2组和第3组的严重疼痛发作伴有胆红素和AST升高更明显,但ALP无明显升高。
传统观点认为梗阻性黄疸中ALP升高超过AST,这在因狭窄导致的黄疸中成立,但在梗阻性结石病中,AST升高可能与ALP相当,甚至在最大黄疸和疼痛发作期间超过ALP。即使AST是主要升高的酶,临床医生也应考虑肝外胆管梗阻的可能性。